Navigation Links
UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
Date:3/25/2008

Leading CNS experts collaborate with UBC to provide best science available

BETHESDA, Md., March 25 /PRNewswire/ -- To offer clients cutting-edge thinking in study methodology for CNS clinical trials, United BioSource Corporation (UBC) announces the formation of a European Advisory Board for Data Quality. This Advisory Board was established to support UBC in its ongoing efforts to improve data quality and outcomes in CNS trials that rely on subjective measurements as pivotal endpoints, such as those in psychiatry, neurology and pain. Recommendations of this Board will be integrated into UBC's customized training and validated assessment programs targeting investigators and study personnel.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080325/NETU079 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )

Specifically, the European Advisory Board will collaborate with UBC in researching the latest methodologies in rater-training, inter-rater reliability assessments and clinician-rated scales, with a focus on enhancing scoring ability, interviewing competency and diagnostic skills for both investigators and other clinicians supporting clinical trials.

The Advisory Board will be led by Oto Markovic, MD, Regional Manager of UBC's European Regional Headquarters in Prague, Czech Republic. Joining Dr. Markovic on the Board will be six leading experts in the fields of CNS, psychiatry and neurology:

-- W. Wolfgang Fleischhacker, MD, is Vice Chair and Professor in the

Department of Psychiatry at Innsbruck University Clinics in Austria,

where he also serves as head of the Department of Biological Psychiatry.

He is a certified psychotherapist with a specialty in behavioral

therapy.

-- Heinz C.R. Grunze, MD, is Professor of Clinical Psychiatry, School of

Neurology, Neurobiology and Psychiatry, University of Newcastle upon

Tyne. Prof. Grunze serves as an editorial reviewer on many journals

and has served as vice president of the International Society of

Bipolar Disorder (ISBD).

-- Cyril Hoschl, MD, DSc., FRCPsych., is Professor of Psychiatry and

department chairman at the Charles University in Prague and Director at

the Prague Psychiatric Centre. Since 2004, he has also served as a

Professor of Psychiatry at the University of P.J. Safarik in Kosice,

Slovak Republic. Dr. Hoschl is the president of the Association of

European Psychiatrists and the vice-president of the Vienna School of

Clinical Research.

-- Norman Sartorius, MD, PhD, FRCPsych., holds professorial appointments

at the Universities of Geneva, Prague and Zagreb, as well as at several

other universities in Europe, the USA and China. He has also served as

the former president of both the World Psychiatric Association and the

European Association of Psychiatrists. Dr. Sartorius has published

more than 300 articles in scientific journals, co-authored several

books and edited numerous others.

-- Stuart A. Montgomery, MD, is Professor Emeritus of Medicine at the

Imperial College School of Science and Medicine, University of London.

Co-author of the Montgomery-Asberg Depression Rating Scale, Dr.

Montgomery holds numerous university and society appointments. He has

published 26 books and more than 400 papers.

-- Eduard Vieta, MD, is Professor of Psychiatry and Director of the

Bipolar Disorders Program of the Hospital Clinic at the University of

Barcelona, Barcelona, Spain. He also serves as Director of Research at

the Clinical Institute of Neuroscience and he currently leads the

Bipolar Research Program at the Spanish Research Network on Mental

Disorders.

According to Professor Montgomery, "The issue of ratings quality and clinical outcomes is critical to the successful development of new CNS drugs. Focusing on improving these outcomes will hopefully lead to the availability of newer and better treatments for patients."

"This world-class group of researchers will guide our efforts to design and execute the most effective rater training and data quality programs based on proven methods and the latest scientific techniques, with a goal of enhancing outcomes in CNS clinical trials," adds Dr. Marcovic.

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Eastern and Western Europe and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.

+1 (240) 644-0420

info@unitedbiosource.com


'/>"/>
SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Allegheny General Hospital Performs First Liver Transplant
2. Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
3. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
5. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
8. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
11. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):